These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Morphologic spectrum of hepatocellular carcinoma in fine needle aspiration biopsies. Ali MA, Akhtar M, Mattingly RC. Acta Cytol; 1986; 30(3):294-302. PubMed ID: 3012921 [Abstract] [Full Text] [Related]
4. Fine needle aspiration biopsy of hepatocellular carcinoma. Some unusual features. Wee A, Nilsson B, Chan-Wilde C, Yap I. Acta Cytol; 1991; 35(6):661-70. PubMed ID: 1659093 [Abstract] [Full Text] [Related]
5. Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy. Solé M, Calvet X, Cuberes T, Maderuelo F, Bruix J, Bru C, Rey MJ, Serna N, Cardesa A. Acta Cytol; 1993; 37(3):309-16. PubMed ID: 8388606 [Abstract] [Full Text] [Related]
6. Cytologic features and histologic correlations of microacinar and microtrabecular types of well-differentiated hepatocellular carcinoma in fine-needle aspiration biopsy. Yang GC, Yang GY, Tao LC. Cancer; 2004 Feb 25; 102(1):27-33. PubMed ID: 14968415 [Abstract] [Full Text] [Related]
9. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL. Diagn Cytopathol; 2004 Jan 25; 30(1):1-6. PubMed ID: 14696137 [Abstract] [Full Text] [Related]
10. Cytodiagnostic accuracy of hepatic malignancy by fine needle aspiration biopsy. Mondal A. J Indian Med Assoc; 1991 Aug 25; 89(8):222-4. PubMed ID: 1660905 [Abstract] [Full Text] [Related]
12. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver. Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A. Cytopathology; 2008 Aug 25; 19(4):229-35. PubMed ID: 18070122 [Abstract] [Full Text] [Related]